Microsoft: Fiscal Q4 Earnings Consensus Estimates

Microsoft (NASDAQ: MSFT) will be reporting their fiscal fourth quarter financials on July 27 after markets close. Analysts have a consensus $306.13 12-month price target on the company, via a total of 40 analysts, with 18 analysts having strong buy ratings. 20 analysts meanwhile have buy ratings and two have hold ratings. The street high sits at a $378 price target, and the lowest target sits at $256.70.

23 analysts have revenue estimates for the fourth quarter. The mean revenue estimate between all 23 analysts is $44.243 billion; this number has been revised upwards from $41.9 billion at the start of the year. The highest revenue estimate is $44.869 billion, while the lowest is $43.629 billion.

Onto EBITDA estimates, there are currently only 5 analysts who have fourth-quarter EBITDA estimates. The mean is currently $20.747 billion, with this number having been revised up from $18.474 billion at the start of the year. Street high is $20.915 billion EBITDA estimate and the lowest is $20.229 billion.

Analysts estimate that quarterly earnings per share will come in at $1.92, with this number being revised upwards from $1.71 at the start of the year. Street high is $2.03 and the lowest estimate is $1.81 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Can the World Actually Supply $6 Copper? | Greg Ferron – PTX Metals

1911 Gold: The Power Of A Mine Restart

Is Gold Repeating the 2005 Setup Before The Big Run? | Geordie Mark

Recommended

Goliath Resources Sees 13% Grade Boost As Stifel Draws Parallels To Great Bear

First Majestic Q4 2025: Record Revenue, Earnings, Annual Silver Output

Related News

Canaccord Reiterates $1.75 Price Target For Mind Medicine Following Roadshow Event

This morning, Canaccord released a flash update for Mind Medicine (NEO: MMED) with highlights from...

Monday, September 28, 2020, 11:02:24 AM

Kazatomprom: BMO Lowers Target To $47.50 Following “Erosion of Sentiment”

Last week Kazatomprom (LSE: KAP), one of the largest uranium producers reported it’s full-year 2021...

Sunday, March 27, 2022, 01:10:00 PM

Xebec: BMO Downgrades, Slashes Price Target As Rising Costs Hit Bottom Line

On May 12, Xebec Adsorption (TSX: XBC) announced its first quarter financial results. The company...

Thursday, May 19, 2022, 03:52:00 PM

K92 Mining: Canaccord Raises Target To $12.50 From $8.75

Yesterday morning Canaccord analyst Tom Gallo upgraded his twelve-month price target on K92 Mining (TSXV:...

Wednesday, October 7, 2020, 12:33:00 PM

Paypal: Consensus Price Target Jumps To $314 Following Q1 Results

Paypal Holdings (NASDAQ: PYPL) ended last week down almost 5% following the release of its...

Tuesday, May 11, 2021, 10:48:00 AM